Hyperglycemia Induced by COVID-19 with and Without Present Diabetes: A Systematic Review
June 30, 2021  //  DOI: 10.24123/kesdok.V2i2.4431
Gembong Satria Mahardhika

Metrics

  • Eye Icon 0 views
  • Download Icon 0 downloads
Metrics Icon 0 views  //  0 downloads
Abstract

—COVID-19 is a major emerging disease that affects any certain condition. However, a recent report suggests the occurrence of hyperglycemia without any present diabetes in COVID-19 patients. This study aimed to systematically review recent evidence on hyperglycemia in COVID-19 patients. Literature research was done using four search engines, consist of Google Scholar, PubMed, ScienceDirect, and ProQuest, and limited to English manuscript only and published from February 2020 to September 2020. SARS-CoV-2 could damage the pancreas by causing the destruction of the β-cell structure that leads to impairment of glucose metabolism and worsen pre-existing diabetes or determine the appearance of hyperglycemia in non-diabetes. Inflammation also plays a major important role in hyperglycemia related to COVID-19.  Hyperglycemia increased the vulnerability of the lung, by promoting and facilitating the entry of the SARS-CoV-2 into the host cells, and decreasing lung function. Moreover, the mortality and morbidity rate conceivable increased due to hyperglycemia. The presence of high glucose levels is linked with the progression of COVID-19 severity. Thus, the glucose level should be concerned, either in a patient with present diabetes or without any presence of diabetes. Examination and monitoring of glucose levels might be a useful tool to prevent the seriousness of COVID-19
Keywords: diabetes mellitus, SARS-CoV-2, high glucose level, pulmonary infection

Full text
Show more arrow
 

Metrics

  • Eye Icon 0 views
  • Download Icon 0 downloads
Metrics Icon 0 views  //  0 downloads